Cytrx reported 3.28M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Bioline Rx BLRX:US $ 63.41M 4.67M
Brainstorm Cell Therapeutics BCLI:US $ 14.49M 4.86M
Celldex Therapeutics CLDX:US $ 398.1M 21.38M
Curis CRIS:US $ 75.97M 14.73M
Cytrx CYTR:US 3.28M 1.5M
Glaxosmithkline GSK:US $ 16181M 1126M
Johnson & Johnson JNJ:US $ 74709M 686M
Karyopharm Therapeutics KPTI:US $ -83079000 3.41M
Northwest Biotherapeutics NWBO:US -120525000 3.47M
Novartis NVS:US $ 61540M 6115M
Seattle Genetics SGEN:US $ 2998.47M 66.67M
Takeda 4502:JP Y 5683019M 351690M